News
The recent results of tolebrutinib in non-active secondary progressive MS presented at the ECTRIMS 2024 conference, reinforce the scientific hypothesis that targeting microglia in nSPMS is a valid ...
The Trump administration plans to accept a luxury Boeing 747-800 plane as a donation from the Qatari royal family that will ...
15h
The Healthy @Reader's Digest on MSNKetamine Therapy: A Medical Doctor Explains Its Use for Treatment-Resistant DepressionHe completed a fellowship in Interventional Neuropsychiatry and Neuromodulation at Massachusetts General Hospital, bringing extensive expertise to the management of treatment-resistant mental health ...
22h
Futurism on MSNThe FDA Will Use AI to Accelerate Approving DrugsSupposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results